Lee's Pharmaceutical Secures Funding from Gates Foundation for Synthetic Surfactant Project

Stock News

Jun 01

Lee's Pharmaceutical (00950) has announced it will receive financial support from the Gates Foundation for its synthetic surfactant project.

The short-term objective of the funded initiative is to successfully complete the research and development of the active pharmaceutical ingredient (API), the formulation, and the manufacturing process for the drug.

The ultimate goal is to introduce this life-saving medication at an affordable price to low- and middle-income countries, specifically to aid premature infants suffering from respiratory distress syndrome.

The board of directors believes the financial backing from the Gates Foundation aligns well with the company's strategic focus in pediatrics and rare diseases.

This support underscores the group's ongoing commitment to improving global access to healthcare and utilizing its innovative drug delivery platform to address critical unmet medical needs.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1138672339"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1138672339\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1138672339?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 22:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138672339","market":"nz","top_or_hot":-1,"title":"Lee's Pharmaceutical Secures Funding from Gates Foundation for Synthetic Surfactant Project","media":"Stock News","content":"<p>Lee's Pharmaceutical (00950) has announced it will receive financial support from the Gates Foundation for its synthetic surfactant project.<br><br>The short-term objective of the funded initiative is to successfully complete the research and development of the active pharmaceutical ingredient (API), the formulation, and the manufacturing process for the drug.<br><br>The ultimate goal is to introduce this life-saving medication at an affordable price to low- and middle-income countries, specifically to aid premature infants suffering from respiratory distress syndrome.<br><br>The board of directors believes the financial backing from the Gates Foundation aligns well with the company's strategic focus in pediatrics and rare diseases.<br><br>This support underscores the group's ongoing commitment to improving global access to healthcare and utilizing its innovative drug delivery platform to address critical unmet medical needs.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lee's Pharmaceutical Secures Funding from Gates Foundation for Synthetic Surfactant Project</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLee's Pharmaceutical Secures Funding from Gates Foundation for Synthetic Surfactant Project\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-01 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lee's Pharmaceutical (00950) has announced it will receive financial support from the Gates Foundation for its synthetic surfactant project.<br><br>The short-term objective of the funded initiative is to successfully complete the research and development of the active pharmaceutical ingredient (API), the formulation, and the manufacturing process for the drug.<br><br>The ultimate goal is to introduce this life-saving medication at an affordable price to low- and middle-income countries, specifically to aid premature infants suffering from respiratory distress syndrome.<br><br>The board of directors believes the financial backing from the Gates Foundation aligns well with the company's strategic focus in pediatrics and rare diseases.<br><br>This support underscores the group's ongoing commitment to improving global access to healthcare and utilizing its innovative drug delivery platform to address critical unmet medical needs.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"","article_id":"1138672339","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138672339","pubTimestamp":1780323016,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Lee's Pharmaceutical (00950) has announced it will receive financial support from the Gates Foundation for its synthetic surfactant project.The short-term objective of the funded initiative is to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","BK1191":"制药","BK1587":"次新股","00950":"李氏大药厂","06622":"兆科眼科-B","BK1574":"生物医药B类股"},"translate_title":"李氏制药获得盖茨基金会对合成表面活性剂项目的资助","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00950":1,"06622":1},"content_text":"Lee's Pharmaceutical (00950) has announced it will receive financial support from the Gates Foundation for its synthetic surfactant project.The short-term objective of the funded initiative is to successfully complete the research and development of the active pharmaceutical ingredient (API), the formulation, and the manufacturing process for the drug.The ultimate goal is to introduce this life-saving medication at an affordable price to low- and middle-income countries, specifically to aid premature infants suffering from respiratory distress syndrome.The board of directors believes the financial backing from the Gates Foundation aligns well with the company's strategic focus in pediatrics and rare diseases.This support underscores the group's ongoing commitment to improving global access to healthcare and utilizing its innovative drug delivery platform to address critical unmet medical needs.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}